-   directed: true
    graph:
        disease: Cystic fibrosis
        disease_mesh: MESH:D003550
        drug: Dornase alfa
        drug_mesh: MESH:C568813
        drugbank: DB:DB00003
    links:
    -   key: positively regulates
        source: MESH:C568813
        target: GO:0000737
    -   key: disrupts
        source: GO:0000737
        target: MESH:D004247
    -   key: positively correlated with
        source: MESH:D004247
        target: UBERON:0016553
    -   key: positively correlated with
        source: UBERON:0016553
        target: MESH:D003550
    multigraph: true
    nodes:
    -   id: MESH:C568813
        label: Drug
        name: Dornase alfa
    -   id: GO:0000737
        label: BiologicalProcess
        name: DNA catabolic process, endonucleolytic
    -   id: MESH:D004247
        label: ChemicalSubstance
        name: DNA
    -   id: UBERON:0016553
        label: GrossAnatomicalStructure
        name: Respiratory system mucus
    -   id: MESH:D003550
        label: Disease
        name: Cystic fibrosis
    reference: 
    - https://go.drugbank.com/drugs/DB00003
    - https://en.wikipedia.org/wiki/Dornase_alfa
-   directed: true
    graph:
        disease: Primary cutaneous T-cell lymphoma
        disease_mesh: MESH:D016410
        drug: bexarotene
        drug_mesh: MESH:C095105
        drugbank: DB:DB00307
    links:
    -   key: increases activity of
        source: MESH:C095105
        target: UniProt:P19793
    -   key: increases activity of
        source: MESH:C095105
        target: UniProt:P28702
    -   key: increases activity of
        source: MESH:C095105
        target: UniProt:P48443
    -   key: negatively regulates
        source: UniProt:P19793
        target: HP:0031379
    -   key: negatively regulates
        source: UniProt:P28702
        target: HP:0031379
    -   key: negatively regulates
        source: UniProt:P48443
        target: HP:0031379
    -   key: positively correlated with
        source: HP:0031379
        target: MESH:D016410
    multigraph: true
    nodes:
    -   id: MESH:C095105
        label: Drug
        name: Bexarotene
    -   id: UniProt:P19793
        label: Protein
        name: Retinoic acid receptor RXR-alpha
    -   id: UniProt:P28702
        label: Protein
        name: Retinoic acid receptor RXR-beta
    -   id: UniProt:P48443
        label: Protein
        name: Retinoic acid receptor RXR-gamma
    -   id: HP:0031379
        label: PhenotypicFeature
        name: Abnormal T cell proliferation
    -   id: MESH:D016410
        label: Disease
        name: Primary cutaneous T-cell lymphoma
    reference: 
    - https://go.drugbank.com/drugs/DB00307#BE0000412 
    - https://en.wikipedia.org/wiki/Bexarotene
    - https://pubmed.ncbi.nlm.nih.gov/16634713/
-   directed: true
    graph:
        disease: Hyperuricemia
        disease_mesh: MESH:D033461
        drug: probenecid
        drug_mesh: MESH:D011339
        drugbank: DB:DB01032
    links:
    -   key: decreases activity of
        source: MESH:D011339
        target: UniProt:Q4U2R8
    -   key: decreases activity of
        source: MESH:D011339
        target: UniProt:Q9NSA0
    -   key: decreases activity of
        source: MESH:D011339
        target: UniProt:Q8TCC7
    -   key: positively regulates
        source: UniProt:Q4U2R8
        target: GO:0015711
    -   key: positively regulates
        source: UniProt:Q9NSA0
        target: GO:0015711
    -   key: positively regulates
        source: UniProt:Q8TCC7
        target: GO:0015711
    -   key: increases abundance of
        source: GO:0015711
        target: MESH:D014527
    -   key: contributes to
        source: MESH:D014527
        target: MESH:D033461
    multigraph: true
    nodes:
    -   id: MESH:D011339
        label: Drug
        name: Probenecid
    -   id: UniProt:Q4U2R8
        label: Protein
        name: Solute carrier family 22 member 6
    -   id: UniProt:Q9NSA0
        label: Protein
        name: Solute carrier family 22 member 11
    -   id: UniProt:Q8TCC7
        label: Protein
        name: Solute carrier family 22 member 8
    -   id: GO:0015711
        label: BiologicalProcess
        name: Organic anion transport
    -   id: MESH:D014527
        label: ChemicalSubstance
        name: Uric Acid
    -   id: MESH:D033461
        label: Disease
        name: Hyperuricemia
    reference: 
    - https://go.drugbank.com/drugs/DB01032#BE0000879
-   directed: true
    graph:
        disease: Articular gout
        disease_mesh: MESH:D015210
        drug: probenecid
        drug_mesh: MESH:D011339
        drugbank: DB:DB01032
    links:
    -   key: decreases activity of
        source: MESH:D011339
        target: UniProt:Q4U2R8
    -   key: decreases activity of
        source: MESH:D011339
        target: UniProt:Q9NSA0
    -   key: decreases activity of
        source: MESH:D011339
        target: UniProt:Q8TCC7
    -   key: positively regulates
        source: UniProt:Q4U2R8
        target: GO:0015711
    -   key: positively regulates
        source: UniProt:Q9NSA0
        target: GO:0015711
    -   key: positively regulates
        source: UniProt:Q8TCC7
        target: GO:0015711
    -   key: increases abundance of
        source: GO:0015711
        target: MESH:D014527
    -   key: contributes to
        source: MESH:D014527
        target: MESH:D015210
    multigraph: true
    nodes:
    -   id: MESH:D011339
        label: Drug
        name: Probenecid
    -   id: UniProt:Q4U2R8
        label: Protein
        name: Solute carrier family 22 member 6
    -   id: UniProt:Q9NSA0
        label: Protein
        name: Solute carrier family 22 member 11
    -   id: UniProt:Q8TCC7
        label: Protein
        name: Solute carrier family 22 member 8
    -   id: GO:0015711
        label: BiologicalProcess
        name: Organic anion transport
    -   id: MESH:D014527
        label: ChemicalSubstance
        name: Uric Acid
    -   id: MESH:D015210
        label: Disease
        name: Articular gout
    reference: 
    - https://go.drugbank.com/drugs/DB01032#BE0000879
-   comment: Pimavanserin is used for the treatment of hallucinations and delusions caused by Parkinson's Disease.
    directed: true
    graph:
        disease: Parkinson's disease
        disease_mesh: MESH:D010300
        drug: pimavanserin
        drug_mesh: MESH:C510793
        drugbank: DB:DB05316
    links:
    -   key: decreases activity of
        source: MESH:C510793
        target: UniProt:P28223
    -   key: positively correlated with
        source: UniProt:P28223
        target: MESH:D012701
    -   key: positively correlated with
        source: MESH:D012701
        target: GO:0060096
    -   key: positively correlated with
        source: GO:0060096
        target: HP:0000709
    -   key: occurs in
        source: HP:0000709
        target: MESH:D010300
    multigraph: true
    nodes:
    -   id: MESH:C510793
        label: Drug
        name: Pimavanserin
    -   id: UniProt:P28223
        label: Protein
        name: 5-hydroxytryptamine receptor 2A
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin 
    -   id: GO:0060096
        label: BiologicalProcess
        name: Serotonin secretion, neurotransmission
    -   id: HP:0000709
        label: PhenotypicFeature
        name: Psychosis
    -   id: MESH:D010300
        label: Disease
        name: Parkinson's disease
    reference:
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2111101/
    - https://go.drugbank.com/drugs/DB05316#BE0000451
    - https://pubmed.ncbi.nlm.nih.gov/27686027/
-   comment: Eteplirsen is indicated for treatment of certain individuals with Duchenne muscular dystrophy.
        Its use is limited to those with a confirmed mutation of the DMD gene which would benefit from exon 51 skipping.
    directed: true
    graph:
        disease: Duchenne muscular dystrophy
        disease_mesh: MESH:D020388
        drug: eteplirsen
        drug_mesh: MESH:C000611335
        drugbank: DB:DB06014
    links:
    -   key: positively regulates
        source: MESH:C000611335
        target: GO:0010467
    -   key: positively regulates
        source: GO:0010467
        target: UniProt:P11532
    -   key: disrupted by
        source: UniProt:P11532
        target: MESH:D020388
    multigraph: true
    nodes:
    -   id: MESH:C000611335
        label: Drug
        name: Eteplirsen
    -   id: GO:0010467
        label: BiologicalProcess
        name: Gene expression
    -   id: UniProt:P11532
        label: Protein
        name: Dystrophin
    -   id: MESH:D020388
        label: Disease
        name: Duchenne muscular dystrophy
    reference: 
    - https://go.drugbank.com/drugs/DB06014
-   directed: true
    graph:
        disease: Hypercholesterolemia
        disease_mesh: MESH:D006937
        drug: Rosuvastatin
        drug_mesh: MESH:D000068718
        drugbank: DB:DB01098
    links:
    -   key: decreases activity of
        source: MESH:D000068718
        target: UniProt:P04035
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D006937
    -   key: increases activity of
        source: MESH:D000068718
        target: UniProt:P01130
    -   key: positively regulates
        source: UniProt:P01130
        target: GO:0034383
    -   key: decreases abundance of
        source: GO:0034383
        target: MESH:D008077
    -   key: positively correlated with
        source: MESH:D008077
        target: MESH:D006937
    multigraph: true
    nodes:
    -   id: MESH:D000068718
        label: Drug
        name: Rosuvastatin
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: Cholesterol biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: UniProt:P01130
        label: Protein
        name: Low-density lipoprotein receptor
    -   id: GO:0034383
        label: BiologicalProcess
        name: Low-density lipoprotein particle clearance
    -   id: MESH:D008077
        label: ChemicalSubstance
        name: Lipoproteins, LDL
    -   id: MESH:D006937
        label: Disease
        name: Hypercholesterolemia
    reference:
    - https://go.drugbank.com/drugs/DB01098#BE0000574
-   directed: true
    graph:
        disease: Mixed hyperlipidemia
        disease_mesh: MESH:D006950
        drug: Rosuvastatin
        drug_mesh: MESH:D000068718
        drugbank: DB:DB01098
    links:
    -   key: decreases activity of
        source: MESH:D000068718
        target: UniProt:P04035
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D006950
    -   key: increases activity of
        source: MESH:D000068718
        target: UniProt:P01130
    -   key: positively regulates
        source: UniProt:P01130
        target: GO:0034383
    -   key: decreases abundance of
        source: GO:0034383
        target: MESH:D008077
    -   key: positively correlated with
        source: MESH:D008077
        target: MESH:D006950
    multigraph: true
    nodes:
    -   id: MESH:D000068718
        label: Drug
        name: Rosuvastatin
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: Cholesterol biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: UniProt:P01130
        label: Protein
        name: Low-density lipoprotein receptor
    -   id: GO:0034383
        label: BiologicalProcess
        name: Low-density lipoprotein particle clearance
    -   id: MESH:D008077
        label: ChemicalSubstance
        name: Lipoproteins, LDL
    -   id: MESH:D006950
        label: Disease
        name: Mixed hyperlipidemia
    reference:
    - https://en.wikipedia.org/wiki/Combined_hyperlipidemia
    - https://go.drugbank.com/drugs/DB01098#BE0000574
-   directed: true
    graph:
        disease: Familial type 3 hyperlipoproteinemia
        disease_mesh: MESH:D006952
        drug: Rosuvastatin
        drug_mesh: MESH:D000068718
        drugbank: DB:DB01098
    links:
    -   key: decreases activity of
        source: MESH:D000068718
        target: UniProt:P04035
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D006952
    -   key: increases activity of
        source: MESH:D000068718
        target: UniProt:P01130
    -   key: positively regulates
        source: UniProt:P01130
        target: GO:0034383
    -   key: decreases abundance of
        source: GO:0034383
        target: MESH:D008077
    -   key: positively correlated with
        source: MESH:D008077
        target: MESH:D006952
    multigraph: true
    nodes:
    -   id: MESH:D000068718
        label: Drug
        name: Rosuvastatin
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: Cholesterol biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: UniProt:P01130
        label: Protein
        name: Low-density lipoprotein receptor
    -   id: GO:0034383
        label: BiologicalProcess
        name: Low-density lipoprotein particle clearance
    -   id: MESH:D008077
        label: ChemicalSubstance
        name: Lipoproteins, LDL
    -   id: MESH:D006952
        label: Disease
        name: Familial type 3 hyperlipoproteinemia
    reference:
    - https://go.drugbank.com/drugs/DB01098#BE0000574
-   directed: true
    graph:
        disease: Cerebrovascular accident
        disease_mesh: MESH:D020521
        drug: Rosuvastatin
        drug_mesh: MESH:D000068718
        drugbank: DB:DB01098
    links:
    -   key: decreases activity of
        source: MESH:D000068718
        target: UniProt:P04035
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D006937
    -   key: increases activity of
        source: MESH:D000068718
        target: UniProt:P01130
    -   key: positively regulates
        source: UniProt:P01130
        target: GO:0034383
    -   key: decreases abundance of
        source: GO:0034383
        target: MESH:D008077
    -   key: positively correlated with
        source: MESH:D008077
        target: MESH:D006937
    -   key: affects risk for
        source: MESH:D006937
        target: MESH:D020521
    multigraph: true
    nodes:
    -   id: MESH:D000068718
        label: Drug
        name: Rosuvastatin
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: Cholesterol biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: UniProt:P01130
        label: Protein
        name: Low-density lipoprotein receptor
    -   id: GO:0034383
        label: BiologicalProcess
        name: Low-density lipoprotein particle clearance
    -   id: MESH:D008077
        label: ChemicalSubstance
        name: Lipoproteins, LDL
    -   id: MESH:D020521
        label: Disease
        name: Cerebrovascular accident
    -   id: MESH:D006937
        label: Disease
        name: Hypercholesterolemia
    reference:
    - https://go.drugbank.com/drugs/DB01098#BE0000574
    - https://en.wikipedia.org/wiki/Stroke
-   directed: true
    graph:
        disease: Hypertriglyceridemia
        disease_mesh: MESH:D015228
        drug: Rosuvastatin
        drug_mesh: MESH:D000068718
        drugbank: DB:DB01098
    links:
    -   key: decreases activity of
        source: MESH:D000068718
        target: UniProt:P04035
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: HP:0002621
    -   key: increases activity of
        source: MESH:D000068718
        target: UniProt:P01130
    -   key: positively regulates
        source: UniProt:P01130
        target: GO:0034383
    -   key: decreases abundance of
        source: GO:0034383
        target: MESH:D008077
    -   key: positively correlated with
        source: MESH:D008077
        target: HP:0002621
    -   key: decreases abundance of
        source: MESH:D000068718
        target: MESH:D014280
    -   key: positively correlated with
        source: MESH:D014280
        target: MESH:D015228
    -   key: positively correlated with
        source: HP:0002621
        target: MESH:D015228
    multigraph: true
    nodes:
    -   id: MESH:D000068718
        label: Drug
        name: Rosuvastatin
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: Cholesterol biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: UniProt:P01130
        label: Protein
        name: Low-density lipoprotein receptor
    -   id: GO:0034383
        label: BiologicalProcess
        name: Low-density lipoprotein particle clearance
    -   id: MESH:D008077
        label: ChemicalSubstance
        name: Lipoproteins, LDL
    -   id: MESH:D014280
        label: ChemicalSubstance
        name: Triglycerides
    -   id: HP:0002621
        label: PhenotypicFeature
        name: Atherosclerosis
    -   id: MESH:D015228
        label: Disease
        name: Hypertriglyceridemia
    reference:
    - https://go.drugbank.com/drugs/DB01098#BE0000574
-   directed: true
    graph:
        disease: Arteriosclerotic vascular disease
        disease_mesh: MESH:D001161
        drug: Rosuvastatin
        drug_mesh: MESH:D000068718
        drugbank: DB:DB01098
    links:
    -   key: decreases activity of
        source: MESH:D000068718
        target: UniProt:P04035
    -   key: positively regulates
        source: UniProt:P04035
        target: GO:0006695
    -   key: increases abundance of
        source: GO:0006695
        target: MESH:D002784
    -   key: positively correlated with
        source: MESH:D002784
        target: MESH:D001161
    -   key: increases activity of
        source: MESH:D000068718
        target: UniProt:P01130
    -   key: positively regulates
        source: UniProt:P01130
        target: GO:0034383
    -   key: decreases abundance of
        source: GO:0034383
        target: MESH:D008077
    -   key: positively correlated with
        source: MESH:D008077
        target: MESH:D001161
    multigraph: true
    nodes:
    -   id: MESH:D000068718
        label: Drug
        name: Rosuvastatin
    -   id: UniProt:P04035
        label: Protein
        name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    -   id: GO:0006695
        label: BiologicalProcess
        name: Cholesterol biosynthetic process
    -   id: MESH:D002784
        label: ChemicalSubstance
        name: Cholesterol
    -   id: UniProt:P01130
        label: Protein
        name: Low-density lipoprotein receptor
    -   id: GO:0034383
        label: BiologicalProcess
        name: Low-density lipoprotein particle clearance
    -   id: MESH:D008077
        label: ChemicalSubstance
        name: Lipoproteins, LDL
    -   id: MESH:D001161
        label: Disease
        name: Arteriosclerotic vascular disease
    reference:
    - https://go.drugbank.com/drugs/DB01098#BE0000574
-   directed: true
    graph:
        disease: Diabetes mellitus type 2
        disease_mesh: MESH:D003924
        drug: glisoxepide
        drug_mesh: MESH:C100171
        drugbank: DB:DB01289
    links:
    -   key: decreases activity of
        source: MESH:C100171
        target: UniProt:Q15842
    -   key: positively correlated with
        source: UniProt:Q15842
        target: GO:0015272
    -   key: negatively correlated with
        source: GO:0015272
        target: GO:0051899
    -   key: positively correlated with
        source: GO:0051899
        target: GO:0070509
    -   key: positively correlated with
        source: GO:0070509
        target: GO:0030073
    -   key: negatively correlated with
        source: GO:0030073
        target: HP:0003074
    -   key: manifestation of
        source: HP:0003074
        target: MESH:D003924
    multigraph: true
    nodes:
    -   id: MESH:C100171
        label: Drug
        name: Glisoxepide
    -   id: UniProt:Q15842
        label: Protein
        name: ATP-sensitive inward rectifier potassium channel 8
    -   id: GO:0015272
        label: BiologicalProcess
        name: ATP-activated inward rectifier potassium channel activity
    -   id: GO:0051899
        label: BiologicalProcess
        name: Membrane depolarization
    -   id: GO:0070509
        label: BiologicalProcess
        name: Calcium ion import
    -   id: GO:0030073
        label: BiologicalProcess
        name: Insulin secretion
    -   id: HP:0003074
        label: PhenotypicFeature
        name: Hyperglycemia
    -   id: MESH:D003924
        label: Disease
        name: Diabetes mellitus type 2
    reference:
    - https://go.drugbank.com/drugs/DB01289#BE0002441
-   directed: true
    graph:
        disease: Diabetes mellitus type 2
        disease_mesh: MESH:D003924
        drug: vildagliptin
        drug_mesh: MESH:C502012
        drugbank: DB:DB04876
    links:
    -   key: negatively regulates
        source: MESH:C502012
        target: UniProt:P27487
    -   key: negatively regulates
        source: UniProt:P27487
        target: CHEBI:80270
    -   key: positively regulates
        source: CHEBI:80270
        target: GO:0030073
    -   key: negatively regulates
        source: CHEBI:80270
        target: GO:0070091
    -   key: negatively regulates
        source: GO:0030073
        target: HP:0003074
    -   key: positively correlated with
        source: GO:0070091
        target: HP:0003074
    -   key: positively correlated with
        source: HP:0003074
        target: MESH:D003924
    multigraph: true
    nodes:
    -   id: MESH:C502012
        label: Drug
        name: Evogliptin
    -   id: UniProt:P27487
        label: Protein
        name: Dipeptidyl peptidase 4
    -   id: CHEBI:80270
        label: ChemicalSubstance
        name: Glucagon-like peptide 1
    -   id: GO:0030073
        label: BiologicalProcess
        name: Insulin secretion
    -   id: GO:0070091
        label: BiologicalProcess
        name: glucagon secretion
    -   id: HP:0003074
        label: PhenotypicFeature
        name: Hyperglycemia
    -   id: MESH:D003924
        label: Disease
        name: Diabetes mellitus type 2
    reference:
    - https://go.drugbank.com/drugs/DB04876
-   directed: true
    graph:
        disease: Chronic obstructive lung disease
        disease_mesh: MESH:D029424
        drug: Aclidinium bromide
        drug_mesh: MESH:C542859
        drugbank: DB:DB08897
    links:
    -   key: decreases activity of
        source: MESH:C542859
        target: UniProt:P20309
    -   key: positively regulates
        source: UniProt:P20309
        target: HP:4000007
    -   key: positively correlated with
        source: HP:4000007
        target: GO:0006954
    -   key: contributes to
        source: GO:0006954
        target: MESH:D029424
    multigraph: true
    nodes:
    -   id: MESH:C542859
        label: Drug
        name: Aclidinium bromide
    -   id: UniProt:P20309
        label: Protein
        name: Muscarinic acetylcholine receptor M3
    -   id: HP:4000007
        label: PhenotypicFeature
        name: Bronchoconstriction
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D029424
        label: Disease
        name: Chronic obstructive lung disease
    reference:
    - https://go.drugbank.com/drugs/DB08897#BE0000045
-   comment: Rimonabant was rejected for approval for use in the United States.
    directed: true
    graph:
        disease: Obesity
        disease_mesh: MESH:D009765
        drug: rimonabant
        drug_mesh: MESH:C089032
        drugbank: DB:DB06155
    links:
    -   key: decreases activity of
        source: MESH:C089032
        target: UniProt:P21554
    -   key: positively correlated with
        source: UniProt:P21554
        target: GO:0032100
    -   key: positively correlated with
        source: GO:0032100
        target: MESH:D009765
    multigraph: true
    nodes:
    -   id: MESH:C089032
        label: Drug
        name: Rimonabant
    -   id: UniProt:P21554
        label: Protein
        name: Cannabinoid receptor 1
    -   id: GO:0032100
        label: BiologicalProcess
        name: Positive regulation of appetite
    -   id: MESH:D009765
        label: Disease
        name: Obesity
    reference: 
    - https://go.drugbank.com/drugs/DB06155
-   comment: This drug is in Phase III clinial trials (as for June 2021).
    directed: true
    graph:
        disease: Deep venous thrombosis
        disease_mesh: MESH:D020246
        drug: bemiparin
        drug_mesh: MESH:C411345
        drugbank: DB:DB09258
    links:
    -   key: decreases activity of
        source: MESH:C411345
        target: UniProt:P00742
    -   key: positively regulates
        source: UniProt:P00742
        target: GO:0072378
    -   key: occurs in
        source: GO:0072378
        target: MESH:D020246
    multigraph: true
    nodes:
    -   id: MESH:C411345
        label: Drug
        name: Bemiparin
    -   id: UniProt:P00742
        label: Protein
        name: Coagulation factor X
    -   id: GO:0072378
        label: BiologicalProcess
        name: Blood coagulation, fibrin clot formation
    -   id: MESH:D020246
        label: Disease
        name: Deep venous thrombosis
    reference:
    - https://go.drugbank.com/drugs/DB09258
-   comment: This drug is in Phase III clinial trials (as for June 2021).
    directed: true
    graph:
        disease: Pulmonary embolism
        disease_mesh: MESH:D011655
        drug: bemiparin
        drug_mesh: MESH:C411345
        drugbank: DB:DB09258
    links:
    -   key: decreases activity of
        source: MESH:C411345
        target: UniProt:P00742
    -   key: positively regulates
        source: UniProt:P00742
        target: GO:0072378
    -   key: occurs in
        source: GO:0072378
        target: MESH:D011655
    multigraph: true
    nodes:
    -   id: MESH:C411345
        label: Drug
        name: Bemiparin
    -   id: UniProt:P00742
        label: Protein
        name: Coagulation factor X
    -   id: GO:0072378
        label: BiologicalProcess
        name: Blood coagulation, fibrin clot formation
    -   id: MESH:D011655
        label: Disease
        name: Pulmonary embolism
    reference:
    - https://go.drugbank.com/drugs/DB09258
-   comment: Alectinib  is specifically used in the treatment of non-small cell lung cancer (NSCLC) 
     expressing the ALK-EML4 (echinoderm microtubule-associated protein-like 4) fusion protein that causes proliferation of NSCLC cells.
    directed: true
    graph:
        disease: Non-small cell lung cancer
        disease_mesh: MESH:D002289
        drug: alectinib
        drug_mesh: MESH:C582670
        drugbank: DB:DB11363
    links:
    -   key: decreases activity of
        source: MESH:C582670
        target: UniProt:Q9UM73
    -   key: positively regulates
        source: UniProt:Q9UM73
        target: REACT:R-HSA-9701898
    -   key: positively regulates
        source: UniProt:Q9UM73
        target: REACT:R-HSA-109704
    -   key: negatively regulates
        source: REACT:R-HSA-9701898
        target: GO:1904019
    -   key: positively regulates
        source: REACT:R-HSA-109704
        target: GO:0050673
    -   key: occurs in
        source: GO:1904019
        target: UBERON:0002048
    -   key: occurs in
        source: GO:0050673
        target: UBERON:0002048
    -   key: location of
        source: UBERON:0002048
        target: MESH:D002289
    multigraph: true
    nodes:
    -   id: MESH:C582670
        label: Drug
        name: Alectinib
    -   id: UniProt:Q9UM73
        label: Protein
        name: ALK tyrosine kinase receptor
    -   id: REACT:R-HSA-9701898
        label: Pathway
        name: STAT3 nuclear events downstream of ALK signalingS
    -   id: REACT:R-HSA-109704
        label: Pathway
        name: PI3K Cascade
    -   id: GO:1904019
        label: BiologicalProcess
        name: Epithelial cell apoptotic process
    -   id: GO:0050673
        label: BiologicalProcess
        name: Epithelial cell proliferation
    -   id: UBERON:0002048
        label: GrossAnatomicalStructure
        name: Lung
    -   id: MESH:D002289
        label: Disease
        name: Non-small cell lung cancer 
    reference:
    - https://go.drugbank.com/drugs/DB11363
-   comment: Telotristat ethylis used for carcinoid syndrome diarrhea. Carcinoid syndrome was not available in MESH.
    directed: true
    graph:
        disease: Diarrhea
        disease_mesh: MESH:D003967
        drug: telotristat ethyl
        drug_mesh: MESH:C000621725
        drugbank: DB:DB12095
    links:
    -   key: has metabolite
        source: DB:DB12095
        target: MESH:C000592493
    -   key: decreases activity of
        source: MESH:C000592493
        target: UniProt:Q8IWU9
    -   key: decreases activity of
        source: MESH:C000592493
        target: UniProt:P17752
    -   key: positively regulates
        source: UniProt:Q8IWU9
        target: GO:0042427
    -   key: positively regulates
        source: UniProt:P17752
        target: GO:0042427
    -   key: increases abundance of
        source: GO:0042427
        target: MESH:D012701
    -   key: positively correlated with
        source: MESH:D012701
        target: HP:0100570
    -   key: positively correlated with
        source: HP:0100570
        target: MESH:D003967
    multigraph: true
    nodes:
    -   id: DB:DB12095
        label: Drug
        name: Telotristat ethyl
    -   id: MESH:C000592493
        label: Drug
        name: Telotristat 
    -   id: UniProt:Q8IWU9
        label: Protein
        name: Tryptophan 5-hydroxylase 2
    -   id: UniProt:P17752
        label: Protein
        name: Tryptophan 5-hydroxylase 1
    -   id: HP:0100570
        label: PhenotypicFeature
        name: Carcinoid tumor
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: GO:0042427
        label: BiologicalProcess
        name: Serotonin biosynthetic process
    -   id: MESH:D003967
        label: Disease
        name: Diarrhea
    reference: 
    - https://go.drugbank.com/drugs/DB12095
